• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种三指标指数可改善对慢性肾脏病贫血中铁紊乱的识别。

A 3-marker index improves the identification of iron disorders in CKD anaemia.

作者信息

Mercadal Lucile, Metzger Marie, Haymann Jean Philippe, Thervet Eric, Boffa Jean-Jacques, Flamant Martin, Vrtovsnik François, Gauci Cédric, Froissart Marc, Stengel Bénédicte

机构信息

Institut National de la Santé et de la Recherche Médicale U1018, CESP Centre for research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France ; Department of Nephrology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Institut National de la Santé et de la Recherche Médicale U1018, CESP Centre for research in Epidemiology and Population Health, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France ; Univ Paris Sud 11, UMRS 1018, Villejuif, France.

出版信息

PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014.

DOI:
10.1371/journal.pone.0084144
PMID:24586229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3929276/
Abstract

BACKGROUND

Iron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia.

METHODS

We studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding capacity (TIBC<50 µmol/L) in 1011 outpatients with non-dialysis CKD participating in the Nephrotest study. All had glomerular filtration rates measured (mGFR) by (51)Cr-EDTA renal clearance; 199 also had hepcidin measures.

RESULTS

The TSAT-TIBC-ferritin index explained Hb variation better than indexes combining TSAT-TIBC or ferritin-TSAT. It showed hypotransferrinaemia and non-inflammatory functional iron deficiency (ID) to be more common than either absolute or inflammatory ID: 20%, 19%, 6%, and 2%, respectively. Hb was lower in all abnormal, compared with normal, iron profiles, and decreased more when mGFR was below 30 mL/min/1.73 m(2) (interaction p<0.0001). In patients with mGFR<30 mL/min/1.73 m(2), the Hb decreases associated with hypotransferrinaemia, non-inflammatory functional ID, and absolute ID were 0.83±0.16 g/dL, 0.51±0.18 and 0.89±0.29, respectively. Compared with normal iron profiles, hepcidin was severely depressed in absolute ID but higher in hypotransferrinaemia.

CONCLUSIONS

The combined TSAT-TIBC-ferritin index identifies hypotransferrinaemia and non-inflammatory functional ID as the major mechanisms of iron disorders in CKD anaemia. Both disorders were associated with a greater decrease in Hb when mGFR was <30 mL/min/1.73 m(2). Taking these iron profiles into account may be useful in stratifying patients in clinical trials of CKD anaemia and might improve the management of iron therapy.

摘要

背景

铁代谢紊乱在慢性肾脏病(CKD)中常见且复杂。我们试图确定一个三指标指数是否能改善CKD贫血中铁代谢紊乱的分类。

方法

我们在参与Nephrotest研究的1011例非透析CKD门诊患者中,研究血红蛋白(Hb)水平与结合以下2种或3种指标的铁指标之间的关联:血清铁蛋白(<40 ng/mL)、转铁蛋白饱和度(TSAT<20%)和总铁结合力(TIBC<50 μmol/L)。所有患者均通过(51)Cr - EDTA肾清除率测定肾小球滤过率(mGFR);199例患者还检测了铁调素水平。

结果

TSAT - TIBC - 铁蛋白指数比结合TSAT - TIBC或铁蛋白 - TSAT的指数能更好地解释Hb变化。结果显示,低转铁蛋白血症和非炎症性功能性缺铁(ID)比绝对缺铁或炎症性ID更常见,分别为20%、19%、6%和2%。与正常铁指标相比,所有异常铁指标状态下的Hb均较低,且当mGFR低于30 mL/min/1.73 m²时下降更明显(交互作用p<0.0001)。在mGFR<30 mL/min/1.73 m²的患者中,与低转铁蛋白血症、非炎症性功能性ID和绝对ID相关的Hb下降分别为0.83±0.16 g/dL、0.51±0.18和0.89±0.29。与正常铁指标相比,铁调素在绝对ID时严重降低,但在低转铁蛋白血症时升高。

结论

联合TSAT - TIBC - 铁蛋白指数可确定低转铁蛋白血症和非炎症性功能性ID是CKD贫血中铁代谢紊乱的主要机制。当mGFR<30 mL/min/1.73 m²时,这两种紊乱均与Hb更大幅度下降相关。在CKD贫血的临床试验中考虑这些铁指标状态可能有助于对患者进行分层,并可能改善铁剂治疗的管理。

相似文献

1
A 3-marker index improves the identification of iron disorders in CKD anaemia.一种三指标指数可改善对慢性肾脏病贫血中铁紊乱的识别。
PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014.
2
The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.慢性肾脏病中,铁调素与铁代谢紊乱、炎症及血红蛋白的关系。
PLoS One. 2014 Jun 30;9(6):e99781. doi: 10.1371/journal.pone.0099781. eCollection 2014.
3
Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.不同缺铁阈值与慢性肾脏病不良结局的关联
BMC Nephrol. 2018 Sep 12;19(1):225. doi: 10.1186/s12882-018-1021-3.
4
Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?非透析慢性肾脏病患者的肾性贫血与水化状态:二者有关联吗?
J Med Life. 2018 Oct-Dec;11(4):293-298. doi: 10.25122/jml-2019-0002.
5
Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).血清铁调素和铁指标根据非透析慢性肾脏病患者的肾功能对贫血状态的影响不同:韩国慢性肾脏病患者结局研究(KNOW-CKD)。
Kidney Blood Press Res. 2017;42(6):1183-1192. doi: 10.1159/000485865. Epub 2017 Dec 8.
6
Serum total iron-binding capacity and iron status in patients with non-dialysis-dependent chronic kidney disease: A cross-sectional study in Vietnam.血清总铁结合力和非透析依赖性慢性肾脏病患者的铁状态:越南的一项横断面研究。
Asia Pac J Clin Nutr. 2020;29(1):48-54. doi: 10.6133/apjcn.202003_29(1).0007.
7
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.非透析慢性肾脏病(CKD)患者的贫血管理:肾科诊所的多中心前瞻性研究。
Nephrol Dial Transplant. 2013 Dec;28(12):3035-45. doi: 10.1093/ndt/gft338. Epub 2013 Oct 21.
8
Association of hepcidin and anemia in early chronic kidney disease.早期慢性肾脏病中,铁调素与贫血的关联。
Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):315-324. doi: 10.4103/1319-2442.256838.
9
Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria.尼日利亚一家三级医院慢性肾脏病成人患者缺铁性贫血及其危险因素评估
Niger Postgrad Med J. 2018 Oct-Dec;25(4):197-203. doi: 10.4103/npmj.npmj_106_18.
10
Ferrokinetics is associated with the left ventricular mass index in patients with chronic kidney disease.铁动力学与慢性肾病患者的左心室质量指数相关。
Acta Cardiol. 2017 Aug;72(4):460-466. doi: 10.1080/00015385.2017.1335382. Epub 2017 Jul 14.

引用本文的文献

1
Prevalence and determinants of anemia in chronic kidney disease patients in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚慢性肾病患者贫血的患病率及影响因素:一项系统评价与荟萃分析
Front Med (Lausanne). 2025 Jun 27;12:1529280. doi: 10.3389/fmed.2025.1529280. eCollection 2025.
2
High Ferritin and Low Total Iron-Binding Capacity in Plasma Predict All-Cause Mortality During the First 3 Years of Hemodialysis in Patients with End-Stage Chronic Kidney Disease.血浆中铁蛋白水平高和总铁结合力低可预测终末期慢性肾病患者血液透析前3年的全因死亡率。
Int J Gen Med. 2024 Jan 12;17:105-113. doi: 10.2147/IJGM.S446115. eCollection 2024.
3

本文引用的文献

1
Timing and determinants of erythropoietin deficiency in chronic kidney disease.慢性肾脏病中促红细胞生成素缺乏的时间和决定因素。
Clin J Am Soc Nephrol. 2012 Jan;7(1):35-42. doi: 10.2215/CJN.04690511. Epub 2011 Nov 17.
2
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice.转铁蛋白是低转铁蛋白血症小鼠中铁调素表达的主要决定因素。
Blood. 2011 Jan 13;117(2):630-7. doi: 10.1182/blood-2010-05-287359. Epub 2010 Oct 18.
3
Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD.
Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts.
慢性肾脏病患者血红蛋白分布的区域差异:国际肾脏病学会慢性肾脏病队列国际网络
Kidney Int Rep. 2023 Aug 12;8(10):2056-2067. doi: 10.1016/j.ekir.2023.07.032. eCollection 2023 Oct.
4
Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort.基于人群的PREVEND队列研究中尿钾排泄、成纤维细胞生长因子23与高血压发病情况
Nutrients. 2021 Dec 17;13(12):4532. doi: 10.3390/nu13124532.
5
Iron metabolism and management: focus on chronic kidney disease.铁代谢与管理:聚焦慢性肾脏病
Kidney Int Suppl (2011). 2021 Apr;11(1):46-58. doi: 10.1016/j.kisu.2020.12.003. Epub 2021 Mar 18.
6
Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated.慢性肾脏病预后和实践模式研究中3-5ND期慢性肾脏病患者的贫血和缺铁情况:常未得到检测,治疗方式各异
Clin Kidney J. 2019 Aug 3;13(4):613-624. doi: 10.1093/ckj/sfz091. eCollection 2020 Aug.
7
Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.铁缺乏、红细胞生成素升高、成纤维细胞生长因子 23 和荷兰一般人群的死亡率:一项队列研究。
PLoS Med. 2019 Jun 6;16(6):e1002818. doi: 10.1371/journal.pmed.1002818. eCollection 2019 Jun.
8
Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.慢性肾脏病血液透析患者对促红细胞生成素α的抵抗:一项纵向研究。
Braz J Med Biol Res. 2018;51(7):e7288. doi: 10.1590/1414-431x20187288. Epub 2018 May 7.
9
Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.口服铁剂治疗(OIT)期间日本血液透析患者伴轻度炎症时缺铁性贫血的最佳血清铁蛋白水平和 OIT 无应答者静脉铁治疗的获益。
Nutrients. 2018 Mar 29;10(4):428. doi: 10.3390/nu10040428.
10
C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.肾移植受者的C端成纤维细胞生长因子23、缺铁与死亡率
J Am Soc Nephrol. 2017 Dec;28(12):3639-3646. doi: 10.1681/ASN.2016121350. Epub 2017 Aug 3.
非透析依赖型 CKD 患者的骨髓铁、铁指标与静脉铁治疗反应。
Am J Kidney Dis. 2010 Apr;55(4):639-47. doi: 10.1053/j.ajkd.2009.10.043. Epub 2010 Jan 15.
4
A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.消化系统疾病中铁缺乏及缺铁性贫血的诊断指南
World J Gastroenterol. 2009 Oct 7;15(37):4638-43. doi: 10.3748/wjg.15.4638.
5
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.在肾脏疾病中,血浆铁调素水平升高,但对促红细胞生成素治疗有反应。
Kidney Int. 2009 May;75(9):976-81. doi: 10.1038/ki.2009.21. Epub 2009 Feb 11.
6
Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients.血液透析患者血清总铁结合力及其随时间的变化与营养和临床结局的关联
Am J Nephrol. 2009;29(6):571-81. doi: 10.1159/000191470. Epub 2009 Jan 9.
7
Transferrin-a modulates hepcidin expression in zebrafish embryos.转铁蛋白-a调节斑马鱼胚胎中的铁调素表达。
Blood. 2009 Mar 19;113(12):2843-50. doi: 10.1182/blood-2008-06-165340. Epub 2008 Dec 1.
8
Timing of onset of CKD-related metabolic complications.慢性肾脏病相关代谢并发症的发病时间。
J Am Soc Nephrol. 2009 Jan;20(1):164-71. doi: 10.1681/ASN.2008020159. Epub 2008 Nov 12.
9
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.1988 - 2004年美国国家健康与营养检查调查中慢性肾病患者的铁指标
Clin J Am Soc Nephrol. 2009 Jan;4(1):57-61. doi: 10.2215/CJN.01670408. Epub 2008 Nov 5.
10
Iron homeostasis: recently identified proteins provide insight into novel control mechanisms.铁稳态:最近发现的蛋白质为新型调控机制提供了见解。
J Biol Chem. 2009 Jan 9;284(2):711-5. doi: 10.1074/jbc.R800017200. Epub 2008 Aug 29.